Business
Odyssey Group International Welcomes World Cup Winner Abby Wambach to Sports Advisory Board
Odyssey Group International Welcomes World Cup Winner Abby Wambach to Sports Advisory Board.
About this update from Odyssey Health Inc.
[{"type":"text","content":"\n Irvine, CA, March 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the \"Company\" or \"Odyssey\"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is honored to welcome retired United States National Soccer Team captain Abby Wambach to its Sports Advisory Board (SAB). The inaugural members of the SAB include notable professional athletes who have a passion to advance treatments for brain injuries.  Wambach is a two-time Olympic gold medalist, World Cup champion, and winner of the FIFA World Player of the Year. A six-time winner of the U.S. Soccer Athlete of the year, she is the record goal scorer for both the Men’s and Women’s National Soccer Teams. Internationally, Wambach is the second highest goal scorer of all time. Wambach joins the growing SAB team that crosses sporting boundaries and includes Brett Favre, Kurt Warner, Steve Mariucci, Mark Rypien and Chicago Cubs manager David Ross. The SAB will support Odyssey’s outreach efforts to enhance public awareness of traumatic brain injuries and concussion as well as the need for an FDA approved treatment. The Company is in the pre-clinical phase of development of a drug compound (PRV-002) and is currently preparing for its first human clinical trial.  Michael Redmond, CEO of Odyssey said, “We are honored to have Abby join our Sports Advisory Board. She is a proven leader and an icon for women, athletes, and fans worldwide. Abby also understands the urgency and importance of the SAB’s mandate. Concussion is a major health issue that affects many facets of our population. With the SAB’s work and the development of PRV-002, we will be able to positively impact outcomes for concussion patients worldwide.”  Wambach added, “I’m thrilled to be involved in such an important project. Concussion is a significant medical issue that needs a proven treatment. I’m hopeful that PRV-002 can provide this unmet need and am happy to be associated with this effort.” About Odyssey Group International, Inc.Odyssey Group International, Inc. (OTCQB:ODYY) is a technology and asset acquisition company with a focus in the area of life saving medical solutions. Odyssey's corporate mission is to cr...